内分泌検査の世界市場レポート 2025年

内分泌検査市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR9.5％で40億1,000万米ドルに成長します。予測期間の成長は、内分泌疾患の有病率の増加、国防費の増加、高齢化、認知度の向上と早期診断に起因すると考えられます。予測期間における主な動向には、バイオマーカー検出の進歩、オミックス技術の統合、人工知能と機械学習、品質保証と標準化、共同研究とトランスレーショナル医療などがあります。

糖尿病の有病率の増加は、内分泌検査市場の成長を促進すると予想されます。糖尿病は、高血糖（グルコース）レベルを特徴とする疾患群であり、食生活の乱れ、座りがちなライフスタイル、遺伝的要因、高齢化などの要因により、その有病率が上昇しています。ヘモグロビンA1c、空腹時血糖、Cペプチドなどの検査を含む内分泌検査は、糖尿病の診断、グルコースレベルのモニタリング、インスリンの産生と感受性の評価に不可欠です。例えば、2024年6月、国民保健サービス（NHS）は、40歳未満の糖尿病患者の大幅な増加を報告し、その数は2022年の17万3,166人から2023年には21万6,440人に増加しました。この急増は、若年層における糖尿病有病率の懸念すべき動向を示しています。その結果、糖尿病有病率の増加が内分泌検査ソリューションの需要に拍車をかけています。

内分泌検査市場の主なプレイヤーは、内分泌疾患の診断におけるアクセシビリティと効率性を高めるために、ポイントオブケア検査ソリューションの開発に注力しています。ポイントオブケア検査は迅速な結果を可能にし、息切れや疲労などの症状を示す患者の心不全などの疾患の迅速な診断と管理に役立ちます。例えば、2024年4月、スイスに本社を置く製薬会社ロシュ・ホールディングAGは、インドでポイントオブケアNT-proBNP検査を導入しました。この検査は、心不全（HF）などの心血管疾患のリスクがある糖尿病患者のスクリーニングに特化したもので、早期発見と早期介入を促進します。この検査は、臨床医が高リスクのT2D患者を迅速に特定し、タイムリーに治療を開始することを可能にし、最終的には転帰の改善と患者の幸福につながります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界内分泌検査PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の内分泌検査市場：成長率分析
• 世界の内分泌検査市場の実績：規模と成長, 2019-2024
• 世界の内分泌検査市場の予測：規模と成長, 2024-2029, 2034F
• 世界内分泌検査総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の内分泌検査市場テストの種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• エストラジオール（E2）検査
• 卵胞刺激ホルモン（FSH）検査
• ヒト絨毛性ゴナドトロピン（hCG）ホルモン検査
• 黄体形成ホルモン（LH）検査
• デヒドロエピアンドロステロン硫酸塩（DHEAS）検査
• プロゲステロン検査
• テストステロン検査
• 甲状腺刺激ホルモン（TSH）検査
• プロラクチン検査
• その他のタイプ
• 世界の内分泌検査市場：技術別、実績と予測, 2019-2024, 2024-2029F, 2034F
• タンデム質量分析法
• 免疫測定
• モノクローナル抗体およびポリクローナル抗体技術
• センサー技術
• 臨床化学
• その他のテクノロジー
• 世界の内分泌検査市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 臨床検査室
• 診断センター
• その他のエンドユーザー
• 世界の内分泌検査市場エストラジオール（E2）検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血清エストラジオール検査
• 尿中エストラジオール検査
• 世界の内分泌検査市場卵胞刺激ホルモン（FSH）検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• FSH血清検査
• FSH尿検査
• 世界の内分泌検査市場ヒト絨毛性ゴナドトロピン（hCG）ホルモン検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 定量hCG検査
• 定性hCG検査
• 世界の内分泌検査市場黄体形成ホルモン（LH）検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• LH血清検査
• LH尿検査
• 世界の内分泌検査市場デヒドロエピアンドロステロン硫酸塩（DHEAS）検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血清DHEAS検査
• 唾液DHEAS検査
• 世界の内分泌検査市場プロゲステロン検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血清プロゲステロン検査
• 尿中プロゲステロン検査
• 世界の内分泌検査市場テストステロン検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 無料テストステロン検査
• 総テストステロン検査
• 世界の内分泌検査市場甲状腺刺激ホルモン（TSH）検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• TSH血清検査
• TSH唾液検査
• 世界の内分泌検査市場プロラクチン検査の種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 血清プロラクチン検査
• 血漿プロラクチン検査
• 世界の内分泌検査市場、その他のタイプのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• コルチゾール検査
• インスリン検査
• 成長ホルモン（GH）検査
• アルドステロン検査

第7章 地域別・国別分析

• 世界の内分泌検査市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の内分泌検査市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 内分泌検査市場：競合情勢
• 内分泌検査市場：企業プロファイル
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • Roche Holding Overview, Products and Services, Strategy and Financial Analysis
  • Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Agilent Technologies Inc.
• PerkinElmer Inc.
• BioMerieux SA
• Beckman Coulter Inc.
• Bio-Rad Laboratories Inc.
• SD Biosensor Inc.
• Qiagen N.V.
• Ortho Clinical Diagnostics
• Kronus Inc.
• Randox Laboratories Ltd.
• Fujirebio Diagnostics Inc.
• Inova Diagnostics Inc.
• Sekisui Diagnostics LLC
• Mercodia AB
• ZEUS Scientific Inc.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 内分泌検査市場2029：新たな機会を提供する国
• 内分泌検査市場2029：新たな機会を提供するセグメント
• 内分泌検査市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Endocrine testing involves the diagnostic assessment of hormone levels within the body, typically conducted through blood, urine, or saliva analyses, to evaluate the function of the endocrine system. These tests play a vital role in diagnosing a range of endocrine disorders, such as diabetes, thyroid disorders, adrenal insufficiency, and pituitary gland disorders, enabling healthcare providers to formulate appropriate treatment and management plans for affected patients.

The primary types of endocrine testing encompass various assessments including the estradiol (E2) test, follicle-stimulating hormone (FSH) test, human chorionic gonadotropin (HCG) hormone test, luteinizing hormone (LH) test, dehydroepiandrosterone sulfate (DHEAS) test, progesterone test, testosterone test, thyroid-stimulating hormone (TSH) test, prolactin test, among others. For instance, the Estradiol (E2) Test involves a blood test to measure estradiol levels in the body. These tests utilize diverse technologies such as tandem mass spectrometry, immunoassays, monoclonal and polyclonal antibody technologies, sensor technology, clinical chemistry, among others, and are commonly conducted in hospitals, clinical laboratories, diagnostic centers, and similar healthcare facilities.

The endocrine testing market research report is one of a series of new reports from The Business Research Company that provides endocrine testing market statistics, including endocrine testing industry global market size, regional shares, competitors with a endocrine testing market share, detailed endocrine testing market segments, market trends and opportunities, and any further data you may need to thrive in the endocrine testing industry. This endocrine testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The endocrine testing market size has grown strongly in recent years. It will grow from $2.55 billion in 2024 to $2.8 billion in 2025 at a compound annual growth rate (CAGR) of 9.8%. The growth in the historic period can be attributed to discovery of hormones and endocrine pathways, diagnostic test standardization, public health initiatives, and patient advocacy and empowerment.

The endocrine testing market size is expected to see strong growth in the next few years. It will grow to $4.01 billion in 2029 at a compound annual growth rate (CAGR) of 9.5%. The growth in the forecast period can be attributed to growing prevalence of endocrine disorders, increased defense spending, aging population, awareness and early diagnosis, and increased awareness. Major trends in the forecast period include advancements in biomarker detection, integration of omics technologies, artificial intelligence and machine learning, quality assurance and standardization, and collaborative research and translational medicine.

The increasing prevalence of diabetes is expected to drive the growth of the endocrine testing market. Diabetes is a group of diseases characterized by high blood sugar (glucose) levels, and its prevalence is rising due to factors such as poor dietary habits, sedentary lifestyles, genetic factors, and an aging population. Endocrine testing, including tests like hemoglobin A1c, fasting plasma glucose, and C-peptide, is essential in diagnosing diabetes, monitoring glucose levels, and evaluating insulin production and sensitivity. For example, in June 2024, the National Health Service (NHS) reported a significant increase in diabetes cases among individuals under 40, with the number rising from 173,166 in 2022 to 216,440 in 2023. This surge indicates a concerning trend in diabetes prevalence among younger populations. As a result, the growing prevalence of diabetes is fueling the demand for endocrine testing solutions.

Key players in the endocrine testing market are focusing on developing point-of-care testing solutions to enhance accessibility and efficiency in diagnosing endocrine disorders. Point-of-care testing enables rapid results, aiding in prompt diagnosis and management of conditions such as heart failure in patients displaying symptoms such as shortness of breath and fatigue. For example, in April 2024, Roche Holding AG, a Switzerland-based pharmaceutical company, introduced a point-of-care NT-proBNP test in India. This test is specifically tailored for screening diabetes patients at risk of cardiovascular diseases such as heart failure (HF), facilitating early detection and intervention. It empowers clinicians to identify high-risk T2D patients promptly and initiate timely treatment discussions, ultimately leading to improved outcomes and patient well-being.

In October 2022, Tolmar, a US-based pharmaceutical company, acquired Jatenzo from Clarus Therapeutics, although the financial details remain undisclosed. This acquisition aligns with Tolmar's focus on pediatric endocrinology and men's health, augmenting their portfolio of specialty pharmaceutical products. Clarus Therapeutics, a US-based pharmaceutical company, specializes in developing and commercializing therapies for individuals with endocrine disorders.

Major companies operating in the endocrine testing market are Thermo Fisher Scientific Inc., Abbott Laboratories, Roche Holding, Siemens Healthineers, Quest Diagnostics, Agilent Technologies Inc., PerkinElmer Inc., BioMerieux SA, Beckman Coulter Inc., Bio-Rad Laboratories Inc., SD Biosensor Inc., Qiagen N.V., Ortho Clinical Diagnostics, Kronus Inc., Randox Laboratories Ltd., Fujirebio Diagnostics Inc., Inova Diagnostics Inc., Sekisui Diagnostics LLC, Mercodia AB, ZEUS Scientific Inc., IBL International, Monobind Inc., Agilus Diagnostics, Tosoh Bioscience Inc., DiaSorin S.p.A.

North America was the largest region in the endocrine testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the endocrine testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the endocrine testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The endocrine testing market consists of revenues earned by entities by providing services such as hormone level testing, thyroid function testing, diabetes testing, adrenal function testing, reproductive hormone testing, pituitary function testing, and bone metabolism testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The endocrine testing market also includes sales of assay kits, analyzers, point-of-care testing devices, reagents, software solutions, quality control materials, and calibrators and controls. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Endocrine Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on endocrine testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for endocrine testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The endocrine testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test Type: Estradiol (E2) Test; Follicle Stimulating Hormone (FSH) Test; Human Chorionic Gonadotropin (hCG) Hormone Test; Luteinizing Hormone (LH) Test; Dehydroepiandrosterone Sulfate (DHEAS) Test; Progesterone Test; Testosterone Test; Thyroid Stimulating Hormone (TSH) Test; Prolactin Test; Other Types
• 2) By Technology: Tandem Mass Spectrometry; Immunoassay; Monoclonal And Polyclonal Antibody Technologies; Sensor Technology; Clinical Chemistry; Other Technologies
• 3) By End-User: Hospitals; Clinical Laboratories; Diagnostic Centers; Other End-Users
• Subsegments:
• 1) By Estradiol (E2) Test: Serum Estradiol Test; Urinary Estradiol Test
• 2) By Follicle Stimulating Hormone (FSH) Test: FSH Serum Test; FSH Urine Test
• 3) By Human Chorionic Gonadotropin (hCG) Hormone Test: Quantitative hCG Test; Qualitative hCG Test
• 4) By Luteinizing Hormone (LH) Test: LH Serum Test; LH Urine Test
• 5) By Dehydroepiandrosterone Sulfate (DHEAS) Test: Serum DHEAS Test; Saliva DHEAS Test
• 6) By Progesterone Test: Serum Progesterone Test; Urinary Progesterone Test
• 7) By Testosterone Test: Free Testosterone Test; Total Testosterone Test
• 8) By Thyroid Stimulating Hormone (TSH) Test: TSH Serum Test; TSH Saliva Test
• 9) By Prolactin Test: Serum Prolactin Test; Plasma Prolactin Test
• 10) By Other Types: Cortisol Test; Insulin Test; Growth Hormone (GH) Test; Aldosterone Test
• Companies Mentioned: Thermo Fisher Scientific Inc.; Abbott Laboratories; Roche Holding; Siemens Healthineers; Quest Diagnostics
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Endocrine Testing Market Characteristics

3. Endocrine Testing Market Trends And Strategies

4. Endocrine Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Endocrine Testing Growth Analysis And Strategic Analysis Framework

• 5.1. Global Endocrine Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Endocrine Testing Market Growth Rate Analysis
• 5.4. Global Endocrine Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Endocrine Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Endocrine Testing Total Addressable Market (TAM)

6. Endocrine Testing Market Segmentation

• 6.1. Global Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Estradiol (E2) Test
• Follicle Stimulating Hormone (FSH) Test
• Human Chorionic Gonadotropin (hCG) Hormone Test
• Luteinizing Hormone (LH) Test
• Dehydroepiandrosterone Sulfate (DHEAS) Test
• Progesterone Test
• Testosterone Test
• Thyroid Stimulating Hormone (TSH) Test
• Prolactin Test
• Other Types
• 6.2. Global Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Tandem Mass Spectrometry
• Immunoassay
• Monoclonal And Polyclonal Antibody Technologies
• Sensor Technology
• Clinical Chemistry
• Other Technologies
• 6.3. Global Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Clinical Laboratories
• Diagnostic Centers
• Other End-Users
• 6.4. Global Endocrine Testing Market, Sub-Segmentation Of Estradiol (E2) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serum Estradiol Test
• Urinary Estradiol Test
• 6.5. Global Endocrine Testing Market, Sub-Segmentation Of Follicle Stimulating Hormone (FSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• FSH Serum Test
• FSH Urine Test
• 6.6. Global Endocrine Testing Market, Sub-Segmentation Of Human Chorionic Gonadotropin (hCG) Hormone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Quantitative hCG Test
• Qualitative hCG Test
• 6.7. Global Endocrine Testing Market, Sub-Segmentation Of Luteinizing Hormone (LH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• LH Serum Test
• LH Urine Test
• 6.8. Global Endocrine Testing Market, Sub-Segmentation Of Dehydroepiandrosterone Sulfate (DHEAS) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serum DHEAS Test
• Saliva DHEAS Test
• 6.9. Global Endocrine Testing Market, Sub-Segmentation Of Progesterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serum Progesterone Test
• Urinary Progesterone Test
• 6.10. Global Endocrine Testing Market, Sub-Segmentation Of Testosterone Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Free Testosterone Test
• Total Testosterone Test
• 6.11. Global Endocrine Testing Market, Sub-Segmentation Of Thyroid Stimulating Hormone (TSH) Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• TSH Serum Test
• TSH Saliva Test
• 6.12. Global Endocrine Testing Market, Sub-Segmentation Of Prolactin Test, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Serum Prolactin Test
• Plasma Prolactin Test
• 6.13. Global Endocrine Testing Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cortisol Test
• Insulin Test
• Growth Hormone (GH) Test
• Aldosterone Test

7. Endocrine Testing Market Regional And Country Analysis

• 7.1. Global Endocrine Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Endocrine Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Endocrine Testing Market

• 8.1. Asia-Pacific Endocrine Testing Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Endocrine Testing Market

• 9.1. China Endocrine Testing Market Overview
• 9.2. China Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Endocrine Testing Market

• 10.1. India Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Endocrine Testing Market

• 11.1. Japan Endocrine Testing Market Overview
• 11.2. Japan Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Endocrine Testing Market

• 12.1. Australia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Endocrine Testing Market

• 13.1. Indonesia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Endocrine Testing Market

• 14.1. South Korea Endocrine Testing Market Overview
• 14.2. South Korea Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Endocrine Testing Market

• 15.1. Western Europe Endocrine Testing Market Overview
• 15.2. Western Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Endocrine Testing Market

• 16.1. UK Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Endocrine Testing Market

• 17.1. Germany Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Endocrine Testing Market

• 18.1. France Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Endocrine Testing Market

• 19.1. Italy Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Endocrine Testing Market

• 20.1. Spain Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Endocrine Testing Market

• 21.1. Eastern Europe Endocrine Testing Market Overview
• 21.2. Eastern Europe Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Endocrine Testing Market

• 22.1. Russia Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Endocrine Testing Market

• 23.1. North America Endocrine Testing Market Overview
• 23.2. North America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Endocrine Testing Market

• 24.1. USA Endocrine Testing Market Overview
• 24.2. USA Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Endocrine Testing Market

• 25.1. Canada Endocrine Testing Market Overview
• 25.2. Canada Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Endocrine Testing Market

• 26.1. South America Endocrine Testing Market Overview
• 26.2. South America Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Endocrine Testing Market

• 27.1. Brazil Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Endocrine Testing Market

• 28.1. Middle East Endocrine Testing Market Overview
• 28.2. Middle East Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Endocrine Testing Market

• 29.1. Africa Endocrine Testing Market Overview
• 29.2. Africa Endocrine Testing Market, Segmentation By Test Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Endocrine Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Endocrine Testing Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Endocrine Testing Market Competitive Landscape And Company Profiles

• 30.1. Endocrine Testing Market Competitive Landscape
• 30.2. Endocrine Testing Market Company Profiles
  • 30.2.1. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Roche Holding Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Siemens Healthineers Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Quest Diagnostics Overview, Products and Services, Strategy and Financial Analysis

31. Endocrine Testing Market Other Major And Innovative Companies

• 31.1. Agilent Technologies Inc.
• 31.2. PerkinElmer Inc.
• 31.3. BioMerieux SA
• 31.4. Beckman Coulter Inc.
• 31.5. Bio-Rad Laboratories Inc.
• 31.6. SD Biosensor Inc.
• 31.7. Qiagen N.V.
• 31.8. Ortho Clinical Diagnostics
• 31.9. Kronus Inc.
• 31.10. Randox Laboratories Ltd.
• 31.11. Fujirebio Diagnostics Inc.
• 31.12. Inova Diagnostics Inc.
• 31.13. Sekisui Diagnostics LLC
• 31.14. Mercodia AB
• 31.15. ZEUS Scientific Inc.

32. Global Endocrine Testing Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Endocrine Testing Market

34. Recent Developments In The Endocrine Testing Market

35. Endocrine Testing Market High Potential Countries, Segments and Strategies

• 35.1 Endocrine Testing Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Endocrine Testing Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Endocrine Testing Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer